|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
14.04.26 - 13:48
|
Auxly Announces Normal Course Issuer Bid (PR Newswire)
|
|
|
TORONTO, April 14, 2026 /PRNewswire/ - Auxly Cannabis Group Inc. ("Auxly" or the "Company") (TSX: XLY) (OTCQB: CBWTF) is pleased to announce that it has filed with the Toronto Stock Exchange (the "TSX"), and the TSX has accepted, the Company's notice of intention to make a normal course......
|
|
|
|
|
|
|
14.04.26 - 13:36
|
Clearmind Medicine′s CMND-100 Meets Primary Endpoint in FDA-Approved Phase I/IIa Clinical Trial for Alcohol Use Disorder (GlobeNewswire EN)
|
|
|
Vancouver, Canada, April 14, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, neuroplastogen-derived therapeutics to solve major under-treated health problems, today announced that CMND-100, the Company's proprietary non-hallucinogenic MEAI-based oral drug candidate, for the treatment of Alcohol Use Disorder (AUD) has met the primary endpoint in its FDA-approved Phase I/IIa clinical trial....
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
13.04.26 - 22:45
|
BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update (The Newswire)
|
|
|
VANCOUVER, BC, March 17, 2026 – TheNewswire - BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (“BioVaxys” or the “Company”) is providing this bi-weekly update on the status of the management cease trade order granted on March 3, 2026 (the “MCTO”), by its principal regulator, the British Columbia Securities Commission (the “BCSC”) under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”). The Company announced on March 3, 2026 (the “Default Announcement”), that it was unable to file its audited annual financial statements for the year ended October 31, 2025, the related management's discussion and analysis, and its Form 52-109FV1 CEO and CFO certifications of annual filings (collectively the “Annual Filings”). Under National Instrument 51-102 - Continuous Disclosure Obligations, the Annual Filings were required to be made not later than February 28, 2026.
The Company is actively working with its auditor, Dale Matheson Carr-Hilton ...
|
|
|
|
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
